Feng GAO

Feng GAO

Professor

Biography

Dr. Feng Gao is a Professor of Colorectal Surgery at the Sixth Affiliated Hospital of Sun Yat-sen University, a position supported by the university’s prestigious 100 Top Talents Program. After initial training in computer engineering and brief roles in engineering and finance, Dr. Gao earned his Ph.D. in cancer research, specializing in the application of artificial intelligence and big data technologies. He is a core member of the International Cancer Genome Consortium - Accelerated Research in Genomic Oncology (ICGC-ARGO) Colorectal Cancer (CRC) project. His research primarily focuses on creating AI-driven solutions for colorectal cancer diagnosis and prognosis. Dr. Gao also has a strong interest in translating these cutting-edge techniques to other medical disciplines, including diabetes, reproductive health, pediatrics, and dentistry.

Research Interests

  • Artificial Intelligence
  • Colorectal Cancer

Education

  • Joint PhD in Cancer Biology and Bioinformatics
    City University of Hong Kong & Cornell University
    2015 - 2018
  • Visiting Student in Computer Science and Electronic Engineering
    Kumamoto University
    2007 - 2008
  • BEng in Computer Science and Technology
    Shandong University
    2005 - 2009

Related Publications

† First or co-first author, * Corresponding or co-corresponding author, bold names are lab members

(0001). Pathway analysis of hypoxia-related factors in early colorectal cancer patients with poor prognosis..
(0001). Multi-scope Analysis Driven Hierarchical Graph Transformer for Whole Slide Image Based Cancer Survival Prediction.
(0001). Multi-omics longitudinal analyses in stages I to III CRC patients: Surveillance liquid biopsy test to predict early recurrence and enable risk-stratified postoperative CRC management..
(0001). Lesion-aware dynamic kernel for polyp segmentation.
(0001). Immune-related gene signature in predicting prognosis of early-stage colorectal cancer patients.
(0001). Identification, Development and Validation of a Circulating Mirna-Based Diagnostic Signature for Early Detection of Gastric Cancer.
(0001). Identification, development and validation of a circulating miRNA-based diagnostic signature for early detection of gastric cancer.
(0001). Genome-wide discovery and identification of a novel microrna signature for recurrence prediction in colorectal cancer.
(0001). Genome-Wide Analysis Revealed a Robust Gene Expression Signature to Identify Lymph Node Metastasis in Submucosal Colorectal Cancer.